Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-pu Yang

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 17, 2018
[Research progress of antipsychotics]Fei-pu Yang, Yang He, Zhen Wang, et al.
Acta Pharmacologica Sinica|June 8, 2022
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertensionYi-Fei He, Yin Liu, Jing-Hua Yu, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|June 17, 2018
[Research progress of antipsychotics]Fei-pu Yang, Yang He, Zhen Wang, et al.
Acta Pharmacologica Sinica|June 8, 2022
Pharmacokinetics, mass balance, and metabolism of [<sup>14</sup>C]TPN171, a novel PDE5 inhibitor, in humans for the treatment of pulmonary arterial hypertensionYi-Fei He, Yin Liu, Jing-Hua Yu, et al.
Pageof 1